Regulated product information, live behind every pack.
Replace paper leaflets with governed, standards-based digital product information — verified, versioned, multilingual, and ready for inspection.
PharmaLedger helps pharmaceutical manufacturers replace paper product information with governed, regulator-ready digital infrastructure. It starts with ePI. It expands into supply-chain intelligence and patient engagement on the same product-trust spine — neutral, standards-based, live, and procurement-ready.
The most regulated industry on earth ships its most critical information on paper.
Folded into every carton is a document that cannot be updated, cannot be verified, and is out of date the day the regulator approves a change. Your batch records went digital. Your supply chain went digital. The one artefact that actually reaches the patient did not.
What is behind these numbers?
Based on the industry labelling-change cost model. Assumptions: artwork revision, QA review and approval loops, print, repackaging, obsolete-stock write-off, and market-specific variation handling. Figures are illustrative ranges for a single change in a single market — not upper bounds. The full calculator, adjustable to your portfolio, is part of the briefing.
Download the executive brief (includes the model summary) →Paper fails you twice: in euros, and in hours.
Every paper change has a price tag.
One safety wording update, one market. Follow it through the paper chain — then through the platform.
Now multiply the left side by every SKU, every market, every year.
Stop managing documents. Start operating truth.
The Product Trust Platform is the operating layer for product information: one governed source of truth, verified at every step, delivered to every market, every channel and every patient — the moment it changes.
One neutral platform. Three products.
Hosted by the PharmaLedger Association — governed by its members, not owned by any one of them.
Start with the funded problem. Expand on the same spine.
AstraLabel™ Start here · System of record
The system of record for electronic product information (ePI) — structured, versioned, live in every market at once, with update cycles cut from weeks to days.
Explore AstraLabel on the platformAstraTrace™ Expansion · Supply intelligence
A decision layer over the systems you already run — Daily Pulse, Historical Analytics, Year-on-Year and Shelf Life views that turn hindsight into foresight.
Explore AstraTrace on the platformAstraEngage™ Expansion · Patient interface
The trusted interface between your product and the person taking it — 29 languages, text-to-speech, privacy by design: no personal data is captured on scan.
Explore AstraEngage on the platformOne spine of truth. Three different pay-offs.
The person who owns the mandate isn't the only one who wins. Here's what comes back to each chair.
You find out about shortages when the crisis call starts — and every label change ends as pallets of your stock in a shredder.
The manufacturer playbook Book the supply chain briefingEvery variation is a race between the approval letter and the stock already in the channel — and you carry the gap.
ePI readiness for 2027 Book the regulatory briefingMillions of packs reach patients you never meet — every one an impression you don't own and can't measure.
The patient-side view Book the engagement briefingTransparent pricing. Keep your sovereignty.
Published pricing across the platform — deployment paths for digital product information, supply-chain intelligence tiers, and early-adopter access to the branded patient apps. Start where you are; nothing gets redesigned as you scale.
Fully managed on shared infrastructure with minimal internal resources — the fastest way to be live and compliant.
- Full service: conversion, upload, management
- Turn-key validation package included
- Ideal for pilots and focused portfolios
A dedicated cloud instance with enhanced performance and complete data isolation for scaling portfolios.
- Complete data isolation
- API integration with your systems of record
- Enterprise performance and support
On-premises deployment with full control over infrastructure and data residency — sovereignty by design.
- Full control of infrastructure and residency
- Qualified deployment packages
- Deep integration with e2e systems of record
Includes leaflet conversion, hosting, validation pack, and support. Custom integrations and market-specific services are scoped separately.
Inventory observability for a focused product set — live in weeks, no infrastructure.
- 25k events per month
- 50 GTINs · 5 users
- Core dashboards and alerts
Full observability across your network with API access for your own systems.
- 500k events per month
- 1,000 GTINs · 25 users
- Full API access
Unlimited scale on a dedicated instance, shaped to your network and governance.
- Unlimited events and GTINs
- Dedicated instance
- Enterprise support and SLAs
Add-on modules — product verification, cold-chain intelligence, shortage intelligence, trading partners and more — from €18,000 per year; module pricing in the briefing.
The branded patient apps arrive with the medicine cabinet and adherence tracking. Early-adopter pricing for commitments before general release — the PLA-branded patient app remains included today.
Your brand in the app stores on the platform patients already trust.
- MAH app-store presence, custom branding
- Push notifications
- Scan-to-leaflet and product lookup
The full engagement layer: medicine cabinet, smart reminders, and adherence signals.
- Medicine cabinet and reminders
- Adherence tracking and signals
- Adverse-event reporting integration
Early-adopter pricing applies to commitments made before general release at end Q4 2026.
Every tier includes hosting, validation support, and the platform trust layer. Custom integrations, market-specific services, and migration support are scoped separately.
AstraEngage microsites, consent and programme capabilities are licensed as modular capabilities today — entry tiers that scale to enterprise, with bundle discounts for platform commitment. The PLA-branded patient app is included. Module pricing is shared in the briefing.
Everything internal diligence needs, one link each.
This isn't a trend to watch. It's a schedule to meet.
Japan has been fully digital since 2021. EMA rollout begins with vaccines in Q3 2026. The mandate map is filling in market by market — and the organisations moving now are positioning for controlled execution rather than emergency response.
Infrastructure this critical shouldn't belong to a vendor.
In regulated infrastructure, trust is earned through structure, not promises. The platform is hosted by a not-for-profit association and steered by the companies that run on it — that isn't positioning, it's the legal structure.
Not venture-backed, not for sale. The platform can't be bought, flipped or priced against its members.
Direction is set by the industry that uses it. Your peers sit on the board — not a vendor's investors.
GS1 Digital Link, EMA ePI, FHIR. We implement the standards the industry already agreed on.
Verified audit trails and qualified infrastructure — designed to be shown to a regulator, not explained to one afterwards.
Three stakeholder groups. One ecosystem.
PLA's network spans the full pharmaceutical value chain — from manufacturers and technology providers to patient associations and health authorities. Each group brings something the others cannot: scale, technical capability, regulatory authority, and patient voice.
Pharmaceutical and animal health MAHs use AstraLabel and AstraTrace as commercial platform services. They also shape the platform roadmap through Committees and, at Patron level, through Board representation.
Current MAH members: GSK · MSD · Takeda · Moderna · Elanco
Technology members contribute to the open-source PTP codebase, integrate with the platform via API, and participate in technical standards-setting. PLA's technology committee sets the architecture direction for the platform's evolution.
Standards: GS1 · HL7 FHIR · Hyperledger · EPCIS 2.0
Patient associations ensure that platform development remains patient-centric — not just technically compliant. Their participation in PLA governance anchors the mission in the outcomes that matter: patients receiving trustworthy, accessible medicine information.
Focus: accessibility · adherence · patient safety